Studies of DNA methylation from fungi, plants, and animals indicate that gene body methylation is ancient and highly conserved in eukaryotic genomes, but its role has not been clearly defined. It has been postulated that regulation of alternative splicing of transcripts was an original function of DNA methylation, but a direct experimental test of the effect of methylation on alternative slicing at the whole genome level has never been performed. To do this, we developed a unique method to administer RNA interference (RNAi) in a high-throughput and noninvasive manner and then used it to knock down the expression of DNA methyltransferase 3 (dnmt3), which is required for de novo DNA methylation. We chose the honey bee (Apis mellifera) for this test because it has recently emerged as an important model organism for studying the effects of DNA methylation on development and social behavior, and DNA methylation in honey bees is predominantly on gene bodies. Here we show that dnmt3 RNAi decreased global genomic methylation level as expected and in addition caused widespread and diverse changes in alternative splicing in fat tissue. Four different types of splicing events were affected by dnmt3 gene knockdown, and change in two types, exon skipping and intron retention, was directly related to decreased methylation. These results demonstrate that one function of gene body DNA methylation is to regulate alternative splicing.
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epigenetics | gene regulation | gene silencing | insect O ne of the greatest discoveries of the genomic era is environmental regulation of gene expression; DNA is not just inherited, it is also environmentally responsive. DNA cytosine methylation is an epigenetic mechanism that mediates many environmental influences on gene expression, affecting diverse aspects of organismal function and disease (1) , and is one of the best studied mechanisms (2) . DNA methylation of CG sites in the promoters of genes in plants and some species of animals acts to repress transcription (3) . By contrast, methylation of gene bodies occurs in many species of fungi, plants, and animals (4, 5) , but its function has not been clearly elucidated.
We chose to address this issue with the honey bee (Apis mellifera) because it has emerged as an important model organism for studying the effects of DNA methylation on development and social behavior (6) (7) (8) (9) . Moreover, DNA methylation in honey bees is predominantly on gene bodies (7, 8, 10) . There are striking differences in methylation between alternative castes that develop from a totipotent female egg-worker and queen (11) -that relate to differences in diet, especially components of royal jelly (12) . RNAi silencing of DNA methyl-transferase 3 (dnmt3), which encodes an enzyme involved in de novo methylation (13) , alters developmental fate; worker larvae treated with dnmt3 RNAi show an increased likelihood of developing into queens (11) .
Recent studies in both invertebrates and mammals support the idea that methylation is correlated with alternative splicing (AS) of transcripts (7, 14) . By comparing brain methylomes of queen and worker bees, a correlation was revealed between DNA methylation and AS (7, 8 ). An in vitro study of mammalian cells showed that DNA methylation inhibited the binding of transcription factor CCCTC binding factor (CTCF), which affected alternative splicing (14) . Regulation of AS is a complicated process that also involves spliceosome assembly (7, 15) , chromatin structure (16, 17) , siRNA activity (18), and transcriptional elongation (19), in addition to the apparent action of methylation.
To explore the causal relationship of DNA methylation and AS in vivo, we used the honey bee to test for a direct link between DNA methylation and AS. We decreased DNA methylation by dnmt3 RNA interference (RNAi) and hypothesized that there would be effects on AS.
RNAi has previously been administered to honey bees and other insects for gene knockdown (KD) by injection (20, 21), but this method is time consuming and highly invasive. We developed a unique method to treat large numbers of insects quickly and noninvasively. We coupled small interfering RNA (siRNA) to perfluocarbon-nanoparticles (PFC-NPs) and nebulized the mixture for aerosol application. PFC-NPs have been used in a variety of biomedical applications, including delivery of RNAi to tumor cells (22, 23), but had never before been nebulized.
To test the hypothesis that DNA methylation regulates AS, we used our method to knock down dnmt3 in honey bee abdominal fat tissue. We chose this tissue because abdominal injections of RNAi have proven especially effective (20, 21), and there are extensive gene expression data from honey bee fat body to compare our results to. Insect fat tissue has analogous functions to both liver and adipose tissue in mammals because they are crucial for both carbohydrate metabolism and lipid storage. We used RNAseq and new AS quantification software (24) to evaluate our hypothesis.
Results and Discussion
We first tested the efficacy of our method of administering RNAi. Image analysis indicates that the nebulized nanoparticlesiRNA complex penetrates the spiracles on the thorax and abdomen and travels through the tracheal respiratory system, which functions in insects to deliver oxygen directly to cells via ever-finer branches ending in tracheoles (25). This was shown by spraying caged bees (n = 17-18 bees/cage) with a mixture of PFC-NPs (labeled Alexa 488 in green) and dnmt3 siRNA (labeled Q-670 in red); control bees were sprayed with PFC-NPs (same label in green) and exogenous GFP siRNA (no label). Confocal microscopy revealed that trachea of dnmt3 siRNAtreated bees showed significantly higher levels of red fluorescence compared with nonlabeled control bees (Fig. 1) . Using the same dnmt3 RNAi construct (Fig. S1 ) used previously for a prior honey bee RNAi injection study (11) , aerosol application caused an ∼30% knockdown in fat tissue (n = 44 and 42 control and RNAi bees, respectively, across three biological replicates; Fig. 2 ). We obtained a similar KD by abdominal injection of the PFC-NP-siRNA complex (Fig. S2) . By contrast to these results for the abdomen, no consistent KD was detected in the head, so brain analysis was not pursued. This result was unfortunate but not unexpected, given that the penetration points (spiracles) are located on the thorax and abdomen and not the head (25). These results demonstrate that it is possible to effectively exploit the insect tracheal system to deliver siRNA at least to abdominal cells via nebulizing spray in a rapid and noninvasive manner.
dnmt3 siRNA-treated and control bees were used for genomewide analysis of gene expression, AS, and DNA methylation. We used the TrueSight program to analyze the RNA sequencing 2 . Effects of spraying a nebulized mixture of nanoparticles and small interfering RNA of dnmt3 on dnmt3 expression ± SEM in honey bee abdominal fat body. Results from three biological replicates (bees from unrelated colonies, n = 22 for colony R12; n = 31 for R62, and n = 33 for R54; two-tailed t tests). Analysis of pooled data: mixed-model ANOVA, df = 82, F = 15.52. *P < 0.05, **P < 0.01, ***P < 0.001.
(RNA-seq) data and quantify AS. Detailed description of this application is in ref. 24 . Across treated and control samples, RNA-seq yielded robust expression results for 13,008 genes, estimated to comprise 84.9% of the genes predicted from Assembly 4.5 and Official Gene Set 3.2 of the honey bee genome (http:// hymenopteragenome.org/beebase/?q=gbrowse_amel). KD of dnmt3 caused strong effects on gene expression. A total of 2,613 (17.1%) genes showed significant differential expression due to RNAi treatment. Gene Ontology analysis of a subset of these differentially expressed genes (DEGs) that had orthologs in the Drosophila melanogaster genome (2,121) revealed that dnmt3 KD had particularly strong effects on RNA processing, intracellular transport, and protein catabolic processing (Table S1 ). Approximately 60.3% of the genes were found to be alternatively spliced, which is consistent with findings from Drosophila (26), and lower than in mammals (27, 28).
Comparing our results to previous gene expression studies of fat body, our DEG list also was enriched for genes related to honey bee behavioral maturation, which involves a shift from working in the hive when young to foraging when older (29). We compared our DEG list with DEG lists from fat tissue associated with (i) hive vs. forager bees; (ii) exposure to poor vs. rich diet Examples are shown in detail in Fig. 3 . AEB, alternative exon boundary; ATE, alternative terminal exon; ES, exon skipping; FDR, false discovery rate; IR, intron retention. Gene examples are shown in detail in Fig. 3 . (poor diet accelerates behavioral maturation); and (iii) exposure to queen pheromone (which delays behavioral maturation). There were significant overlaps between the dnmt3 KD DEG list and all three of these DEG lists [298, 368, and 363 genes, respectively; representation factor (RF) = 1.02, 1.37, and 1.37; P = 0.026, 2.36e−12, and 4.34e −12] . There also was a significant overlap of our dnmt3 KD DEG list and the DEG list from the caste determination study that used dnmt3-silenced larvae (11) (RF = 2.62, P = 5.77e−5). These results suggest that nutritional regulation of behavioral maturation involves differential methylation of genes in the honey bee fat body.
KD of dnmt3 caused strong effects on AS. A total of 524 genes showed significant differences in AS due to treatment [false discovery rate (FDR) < 0.1]. Moreover, there were significant differences for four different types of AS events: exon skipping (ES), alternative terminal exons (ATE), alternative exon boundaries (AEB), and intron retention (IR) ( Table 1 ). This result revealed a broader effect of dnmt3 KD on AS than expected. Results with quantitative PCR (qPCR) for selected genes ( Fig. 3; Fig. S3 ) confirmed the effects of dnmt3 KD on AS.
To examine the possibility that dnmt3 KD exerted its effects by altering the expression of genes known to act as AS factors, we investigated the RNA-seq results for all known AS factors or AS factor-like genes in honey bees (by orthology to Drosophila). Of 72 AS factor or AS factor-like genes, 16 were differentially expressed (Table S2 ). There was no correlation between DNA methylation changes in gene bodies or promoter regions and the expression of these 16 genes (r = 0.25 and −0.12, P = 0.35 and 0.66, respectively). We cannot rule out the possibility that changes in expression of AS factor genes caused all of the abovereported change in AS, but we consider this unlikely, given the close association between the RNAi KD-induced changes in methylation and AS that we detected, as we report in the following paragraphs.
To address the issue of whether the effects of dnmt3 KD on AS were due to decreases in DNA methylation, dnmt3 siRNA-treated and control bees were used for genome-wide analysis of DNA methylation by bisulfite sequencing (BS-seq). Using pooled samples for a single analysis of treated and control bees, dnmt3 KD caused a 21% decrease in DNA methylation, similar to the level of KD of dnmt3 itself (∼30%). Sequencing coverage was comprehensive, covering 86.5% of all cytosine-phosphate-guanines (CpGs) with at least one read in the control and 80.1% in the dnmt3 KD sample (Fig. S4) .
BS-seq results support the contention that the effects of dnmt3 KD on AS are at least partly due to decreases in DNA methylation. There was a significant relationship between dnmt3 KD, DNA methylation, and exon skipping: decreased DNA methylation (due to dnmt3 KD) was associated with increased ES (Table 2 ; P = 0.019, two-tailed Fisher's exact test, n = 72 differential exon skipping events; Fig. 4 ). A galactokinase-like gene GB46657 is represented in Fig. 4 as an example of DNA methylation affecting ES. These genome-wide findings are consistent with results from honey bees for a single gene (8) . A study in human cell lines (14) reported that DNA methylation prevented CTCF from binding to the alternative exon, leading to an increase in ES. The specific effect of DNA methylation on AS may vary in different genomic landscapes and in different species (30). Our results provide experimental evidence at the whole-genome level for a direct link between alternative splicing and DNA methylation in a dnmt3 KD background.
BS-seq also revealed a significant association with decreased DNA methylation and less IR (P = 0.044, two-tailed Fisher's exact test; Table 2 ). We did not test for a relationship between DNA methylation levels and AEB or ATE because no practical method has been developed yet: alternative exon boundaries are very short in cases of AEB, and ATE is often close to the regulatory regions. Other mechanisms in addition to DNA methylation are thus likely involved in the regulation of different forms of AS. Our results with BS-seq data demonstrate that DNA methylation of gene bodies affects alternative splicing on a genome-wide scale, specifically for ES and IR.
Alternative splicing of mRNA transcripts is an important mechanism for increasing the diversity and complexity of phenotypes that are generated from a genome (31) and can show strong species-specific differences (32, 33). AS has been shown to play fundamental roles in sex determination, development, behavior, and disease, and in worker honey bees, sterility, which is a hallmark of eusociality (1, 34, 35) . Recently, DNA methylation has been detected in the genomes of other important social insects including several ants and termites (36, 37) and has been implicated in caste differentiation and behavioral maturation (8, 38) . Further studies of DNA methylation and AS will help understand the mechanisms and evolution of phenotypic plasticity.
Materials and Methods
Bees. Honey bees were a mix of European races typical of Illinois, predominantly Apis mellifera ligustica. They were maintained according to standard practices at the University of Illinois Bee Research Facility. We used worker bees derived from single-drone inseminated queens for RNA-seq analysis to reduce interindividual genetic variability and worker bees from a naturally mated queen colony for BS-seq analysis. Treated and control bees for each biological replicate were from the same colony.
RNA Interference Treatment. We administered a nebulized aerosol mixture of PFC-NPs made in the Wickline laboratory and small siRNA for dnmt3 (Sigma). The control was siRNA for EGFP-S1 (IDT). siRNA oligo sequences are given in Table S3 . The doses of PFC-NP and siRNA were 200 pM and 1 μM, respectively, in a total volume of 1,368 μL (mixture of PFC-NP, siRNA, and molecular graded water). A higher ratio of dnmt3 siRNA/NP (200 pM/2 μM) also was tested, but did not appear as efficacious. The reason may be that the number of siRNA molecules per nanoparticle was increased at a higher dose and the charge of the transfection complex changed, so the delivery of the transfection complex was not efficient. This treatment was administered to groups of 17-18 bees for 5 min. After treatment, the bees were placed in a standard Plexiglas cage and held in a dark incubator at 32°C, 40% relative humidity, for 96 h. They were fed pollen paste [50% (wt/vol) honey/50% (wt/vol) pollen] and sugar syrup [50% sucrose (wt/vol) in water], which was replaced daily. Bees were collected 96 h after spray and frozen in liquid nitrogen, and then kept at −80°C for analysis. Abdominal fat bodies were stored in RNAlater-ICE (catalog no. AM7030; Ambion by Life Technologies) overnight and then dissected and stored at −80°C. For injection experiments, PFC-NP:siRNA (10 pM:10 nM) was administered in 400 nL of insect saline solution and administered to 1-d-old bees abdominally. Holding conditions were as for the sprayed bees.
Image Processing to Determine Mode of Action of Nanoparticle-RNAi Spray. To determine whether the nanoparticle-RNAi spray acts by penetrating the insect tracheal respiratory system, 1-d-old bees (n = 17-18) were sprayed with both 1 μM siRNA of GFP control (no labeling) and 200 pM Alexa 488 fluorescently labeled nanoparticles (green) or with 1 μM Q-670 siRNA of dnmt3 (red) and nanoparticles (green) with the above dose. Abdominal spiracles and trachea were dissected in insect saline solution 24 h after spraying. Samples were dehydrated in solutions of 25%, 50%, 75%, 100%, and 100% methanol for 20 min, respectively, and maintained in 100% methyl salicylate until imaging. The images were captured by a Zeiss LSM 700 confocal microscope at 20×.
RNA-seq. We selected individuals showing typical KD for RNA sequencing (6 treated and 6 control). Libraries were made with the TruSeq RNA Table 1 .
Differential Alternative Splicing. We used two sources of information to test the significance of differentially spliced genes (DSGs). The first approach was to use RNAseq coverage, using both fully mapped reads and junction-spanning reads from RNAseq; the second approach was to focus on splice junctions, by counting the number of junction-spanning reads from RNA-seq reads on splice junctions involved in AS.
Testing DSG Using Exon/Intron Coverage (P cov ). DSGs including IR, ES, and ATE were detected based on the coverage ratio changes for the retaining introns, skipped exons, and alternative terminal exons, respectively. An unpaired t test was used to calculate the P value, P cov , from coverage ratios. Because AEBs often differ by just a few base pairs, exon coverage information cannot be generally applied to AEB differential splicing; only splice junction mapping counts were used to calculate P count (see below).
Testing DSG Using Alternative Splice Junction Mapping Counts (P count ). The change in the number of RNA-seq reads mapped onto alternative splice junctions was used to calculate another statistic to test DSG in ES, AEB, and ATE. Fisher's exact test was used to calculate the P value, P count , from alternative splice junction mapping counts. Because IR is for intron expression rather than alternative splice junction, differential IR cannot be tested with junction mappings; only coverage information was used to get P cov (see above). P cov is the final P value for testing IR and P count is the final P value for testing AEB. For ES and ATE, both statistical testing metrics were applied, and we used Fisher's combined probability test to obtain the final P values: χ 2 = −2 log(P cov ) − 2 log(P count ). P values were adjusted for multiple hypotheses testing by using a Benjamini-Hochberg FDR criterion. The detailed testing procedure is described below for each subtype of AS.
Nðx ∼ yÞ = number of reads mapped onto junction x ∼ y Covðx ∼ yÞ = P y i = x number of reads mapped onto i y − x :
Differential intron retention test. For a retained intron with coordinates p ∼ q and two adjacent exons a ∼ p, q ∼ d, its inclusion ratio was calculated as follows:
IR inclusion ratio = 2 p Covðp ∼ qÞ Covða ∼ pÞ + Covðq ∼ dÞ :
Unpaired t tests were used on IR inclusion ratios to get P cov , and on that basis, 27 IRs were determined to be DSG (FDR = 0.1; Benjamini-Hochberg). In the example of IR in Fig. 3 , control is calculated as 2 × 40.6/(168.6 + 159.1) ≈ 0.25; dnmt3 KD is calculated as 2 × 28.8/(196.1 + 201.9) ≈ 0.14. Differential exon skipping test. We applied both metrics to measure changes of ES by dnmt3 KD. For an ES with coordinates p ∼ q and two adjacent constitutive exons a ∼ b, c ∼ d, the ES skipping ratio was calculated as follows:
ES skipping ratio = Covða ∼ bÞ + Covðc ∼ dÞ − 2 p Covðp ∼ qÞ Covða ∼ bÞ + Covðc ∼ dÞ :
P cov was calculated using an unpaired t test.
The second method used the number of junction mapping reads. The ES-containing isoform was represented by I c = int Nðb ∼ pÞ + Nðq ∼ cÞ 2 and the CE-skipping isoform by I s = N(b ∼ c).
For Table 2 , we chose 192 differential exon skipping (DES) events together with their flanking 200-bp intronic regions and computed the average change in methylation for each region in dnmt3 KD vs. control bees. There were 72 DESs overlapping with methylated cytosine-phosphate-guanine (mCpG) sites. Using these 72 DESs, there was a significant relationship between dnmt3 KD, DNA methylation, and DES; decreased methylation (due to dnmt3 knockdown) was associated with increased exon skipping (P = 0.019, two-tailed Fisher's exact test). The same analysis was performed for differential intron retention (DIR). Using 15 DIRs, there was also a strong trend with decreased methylation associated with less intron retention (P = 0.044, two-tailed Fisher's exact test).
Although per-sample RNA-seq coverage is decent in our data, minor isoforms generated from AS might still have low sequencing coverage. Therefore, directly comparing the splice junction (SJ) counting ratios across samples would be misleading. We summed all control and dnmt3 treatment mapping numbers, respectively, performed the Fisher's exact test on the 2 × 2 table h P 6 i=1 I c ðiÞ :
P 6 j=1 I c ðjÞ :
, and calculated P count . Fisher's combined probability test was performed based on coverage and junction read counts, and the final P value calculated from χ 2 = −2 log(P cov )−2 log(P count ), with four degrees of freedom. A total of 192 ESs were selected as DSGs (0.01 FDR; Benjamini-Hochberg). In the example of ES in Fig. 3 , control is calculated as 90/(25 + 46) × 2 ≈ 2.5; dnmt3 KD is calculated as 197/(40 + 62) × 2 ≈ 3.9.
Differential AEB test. Because the majority of AEBs are of a few base pairs difference, the coverage information could not be applied to differentiate the use of AEBs. Instead, we used RNAseq read counts on alternative splice junctions in testing differential AEB, as follows.
Let us assume that for three continuous exons (a ∼ b, p ∼ q, c ∼ d), exon p ∼ q has alternative splice site p′.
The number of isoforms containing junction b ∼ p is I p = N(b ∼ p), and the number of isoforms containing junction b ∼ p′ is I p′ = Nðb ∼ p′Þ. The same Fisher's exact test strategy as used in the differential ES test was applied here in AEB testing.
We determined 141 ATEs to be significantly differentially spliced after dnmt3 KD, at 0.01 FDR (Benjamini-Hochberg). In the example of AEB in Fig. 3 , control is calculated as 121/37 ≈ 3.3; dnmt3 KD is calculated as 110/10 = 11.
Differential ATE test. Assume that we have a constitutive exon (a ∼ b), and two ATEs (c ∼ d, e ∼ f).
Using the coverage information, ATE splicing ratio was calculated as follows:
ATE splicing ratio = Covðc ∼ dÞ Covðc ∼ dÞ + Covðe ∼ f Þ :
P cov was calculated using an unpaired t test. The number of isoforms containing junction b ∼ c is I c = N(b ∼ c), and the number of isoforms containing junction b ∼ e is I e = N(b ∼ e). The same Fisher exact test strategy as used in ES was applied here in ATE testing to calculate P count .
The final P value for ATE was calculated from χ 2 = −2 log (P cov )−2 log(P count ), with four degrees of freedom. In total, 225 ATEs were determined to be DSGs (0.01 FDR; BenjaminiHochberg). In the example of ATE in Fig. 3 , control is calculated as 87/27 ≈ 3.2; dnmt3 KD is calculated as 179/34 ≈ 5.3. . KD effects on dnmt3 mRNA expression by injecting dnmt3 siRNA in the abdomen of honey bees (mean and SEM). Shown are two biological replicates (n = 21 and 22, P values based on two-tailed t-tests) and results from pooled data (mixed-model ANOVA, df = 40, F = 6.18, *P < 0.05). S3 . Validation of dnmt3 RNAi-associated alternative splicing. To validate the splicing results, gene candidates for each type of AS event were selected for qPCR analysis. ES was validated with GB53079 (motile sperm domain-containing protein 1-like) and GB46657 (galactokinase-like); IR with GB49485 (probable prolyl-tRNA synthetase, mitochondrial-like); ATE with gene GB49165 (protein RER1-like); and AEB with gene GB50039 (methionyl-tRNA synthetase). Control: n ≥ 10; dnmt3 KD: n ≥ 10. Mean relative expression levels, SEM, and P values are displayed. Data analyzed with two-tailed t tests. Fig. S4 . Methylation levels for control and dnmt3 KD bees (n = 1 pooled sample for each). Top two graphs show all genes; bottom two graphs show internal exons only. C stands for cytosine, G stands for guanine, H stands for adenine (A), thymine (T), or cytosine (C). The colors blue, green, and red represent CG, CHG, and CHH sequences, respectively. The middle section (underlined blue) of each graph represents the whole gene or just the internal exon. Table S1 . Gene Ontology (biological process) analysis of genes that were differentially expressed between control bees and dnmt3 KD bees (Benjamini cutoff: <0.01) GUCAACGUAGAUUUGACGCdTdT GCGUCAAAUCUACGUUGACdTdT Table S4 . Primers used for qPCR experiments
